当前位置:首页 - 行情中心 - 佐力药业(300181) - 财务分析

佐力药业

(300181)

  

流通市值:104.85亿  总市值:121.97亿
流通股本:6.03亿   总股本:7.01亿

佐力药业(300181)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.18亿元,每股收益0.73元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益318269.86万元,未分配利润94077.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产464330.56万元,负债146060.71万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,279,713,382.851,599,453,446.18824,425,237.082,577,878,166.87
营业总成本1,720,477,214.141,184,629,333.23623,213,469.792,050,169,103.69
其他经营收益
营业利润617,741,588.5451,582,737.74215,782,928.9609,287,521.8
利润总额610,760,250.3447,894,777.16213,737,051.88596,692,741.94
净利润518,111,660.82379,193,091.62183,386,181.52515,958,086.72
每股收益
其他综合收益193,161,979.42266,901,782.73122,157,526.1856,170,995.22
综合收益总额711,273,640.24646,094,874.35305,543,707.7572,129,081.94
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,380,977,141.982,298,188,032.452,436,673,465.922,177,445,545.68
非流动资产:
非流动资产合计2,262,328,465.382,301,207,601.312,132,597,487.631,814,510,308.72
资产总计4,643,305,607.364,599,395,633.764,569,270,953.553,991,955,854.4
流动负债:
流动负债合计1,278,802,587.111,265,310,381.531,211,726,378.451,056,049,174.34
非流动负债:
非流动负债合计181,804,469.12227,222,846.97176,247,420.58116,465,923.94
负债合计1,460,607,056.231,492,533,228.51,387,973,799.031,172,515,098.28
所有者权益(或股东权益):
归属于母公司股东权益合计3,117,125,872.983,038,206,441.683,119,349,403.152,768,884,681.97
股东权益合计3,182,698,551.133,106,862,405.263,181,297,154.522,819,440,756.12
负债和股东权益合计4,643,305,607.364,599,395,633.764,569,270,953.553,991,955,854.4
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,217,743,303.911,549,438,051.75543,904,627.722,737,184,821.02
经营活动现金流出小计1,951,741,862.191,259,854,039.72621,343,007.732,440,137,580.62
经营活动产生的现金流量净额266,001,441.72289,584,012.03-77,438,380.01297,047,240.4
投资活动产生的现金流量:
投资活动现金流入小计6,073,5986,016,998-152,637,738.72
投资活动现金流出小计235,959,253.8172,353,433.32129,980,161.09262,888,474
投资活动产生的现金流量净额-229,885,655.8-166,336,435.32-129,980,161.09-110,250,735.28
筹资活动产生的现金流量:
筹资活动现金流入小计733,114,250540,300,750231,900,750531,376,625
筹资活动现金流出小计876,194,801.29716,195,863.8791,817,446.55870,762,632.22
筹资活动产生的现金流量净额-143,080,551.29-175,895,113.87140,083,303.45-339,386,007.22
汇率变动对现金及现金等价物的影响-96.54-103.54-25.55162.35
现金及现金等价物净增加额-106,964,861.91-52,647,640.7-67,335,263.2-152,589,339.75
期末现金及现金等价物余额668,590,191.23722,907,412.44735,440,496.99775,555,053.14
补充资料:
现金及现金等价物的净增加额--52,647,640.7--152,589,339.75
最新报告期:2025-10-31
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券刘鹏,袁紫馨0.921.111.352025-10-31
中信证券宋硕,陈竹0.921.091.292025-08-22
华西证券崔文亮0.951.201.502025-08-22
长城证券刘鹏,袁紫馨0.951.141.382025-08-21
长江证券张楠,彭英骐0.941.211.552025-08-21
TOP↑